Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2448-2455

  Kordick, Dorsey L ^a   Papich, Mark G ^a   Breitschwerdt, Edward B ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; ENROFLOXACIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BARTONELLA CLARRIDGEIAE; BARTONELLA HENSELAE; BLOOD CULTURE; CAT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RICKETTSIOSIS;

EID: 0030664756     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2448     Document Type: Article

References (38)

1. Altreuther, P. 1992. Safety and tolerance of enrofloxacin in dogs and cats, p. 15-19. In Proceedings of the 1st International Baytril Symposium, Bonn, Germany.
2. Anderson, B. E., and M. A. Neuman. 1997. Bartonella spp. as emerging human pathogens. Clin. Microbiol. Rev. 10:203-219.
3. Aucoin, D. P. 1992. Use of enrofloxacin in chronic infections involving Staphylococcus intermedius or Pseudomonas aeruginosa. Preventing the emergence of resistance, p. 21-25. In Proceedings of the 1st International Baytril Symposium, Bonn, Germany.
4. Bergan, T. 1988. Pharmacokinetics of fluorinated quinolones, p. 119-145. In V. T. Andriole (ed.), The quinolones. Academic Press, New York, N.Y.
5. Bergmans, A. M. C., E. G. J. Hulskotte, C. M. A. de Jong, G. van Amerongen, A. D. M. E. Osterhause, and L. M. Shouls. 1996. Experimental infection of cats and macaques with Bartonella henselae: kinetics of bacteremia and efficacy of antibiotic treatment in cats. Ph.D. thesis. Universiteit Utrecht, Utrecht, The Netherlands.
6. Bogue, C. W., J. D. Wise, G. F. Gray, and K. M. Edwards. 1989. Antibiotic therapy for cat-scratch disease? JAMA 262:813-816.
7. Boothe, D. M. 1989. The practical aspects of treating bacterial infections in cats. Vet. Med. 84:884-904.
8. Breitschwerdt, E. B., D. L. Kordick, D. E. Malarkey, B. Keene, T. L. Hadfield, and K. Wilson. 1995. Endocarditis in a dog due to infection with a novel Bartonella subspecies. J. Clin. Microbiol. 33:154-160.
9. Chomel, B. B., R. C. Abbott, R. W. Kasten, K. A. Floyd-Hawkins, P. H. Kass, C. A. Glaser, N. C. Pedersen, and J. E. Koehler. 1995. Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J. Clin. Microbiol. 33:2445-2450.
10. Chomel, B. B., R. W. Kasten, K. Floyd-Hawkins, B. Chi, K. Yamamoto, J. Roberts-Wilson, A. N. Gurfield, R. C. Abbott, N. C. Pedersen, and J. E. Koehler. 1996. Experimental transmission of Bartonella henselae by the cat flea. J. Clin. Microbiol. 34:1952-1956.
11. Demers, D. M., J. W. Bass, J. M. Vincent, et al. 1995. Cat-scratch disease in Hawaii: etiology and seroepidemiology. J. Pediatr. 127:23-26.
12. Greene, C. E., M. McDermott, P. H. Jameson, C. L. Atkins, and A. M. Marks. 1996. Bartonella henselae infection in cats: evaluation during primary infection, treatment, and rechallenge infection. J. Clin. Microbiol. 34:1682-1685.
13. Hadfield, T. L., R. Warren, M. Kass, E. Brun, and C. Levy. 1993. Endocarditis caused by Rochalimaea henselae. Hum. Pathol. 24:1140-1141.
14. Hof, H. 1991. Intracellular microorganisms: a particular problem for chemotherapy. Infection 19:S193.
15. Holley, H. P. 1991. Successful treatment of cat-scratch disease with ciprofloxacin. JAMA 265:1563-1565.
16. Koehler, J. E., C. A. Glaser, and J. W. Tappero. 1994. Rochalimaea henselae infection: a new zoonosis with the domestic cat as reservoir. JAMA 271:531-535.
17. Kordick, D. L., K. H. Wilson, D. J. Sexton, T. L. Hadfield, H. A. Berkhoff, and E. B. Breitschwerdt. 1995. Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients. J. Clin. Microbiol. 33:3245-3251.
18. Kordick, D. L., and E. B. Breitschwerdt. 1995. Intraerythrocytic presence of Bartonella henselae. J. Clin. Microbiol. 33:1655-1656.
19. Kordick, D. L., B. Swaminathan, C. E. Greene, K. H. Wilson, A. M. Whitney, S. O'Connor, D. G. Hollis, G. M. Matar, A. G. Steigerwalt, G. B. Malcolm, P. S. Hayes, T. L. Hadfield, E. B. Breitschwerdt, and D. J. Brenner. 1996. Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii. Int. J. Syst. Bacteriol. 46:704-709.
20. Kordick, D. L., and E. B. Breitschwerdt. 1997. Relapsing bacteremia following blood transmission of Bartonella henselae to cats. Am. J. Vet. Res. 58:492-497.
21. Kordick, D. L., E. J. Hilyard, T. L. Hadfield, K. H. Wilson, A. G. Steigerwalt, D. J. Brenner, and E. B. Breitschwerdt. 1997. Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papule, fever, and lymphadenopathy (cat scratch disease). J. Clin. Microbiol. 35:1813-1818.
22. Kordick, D. L., and E. B. Breitschwerdt. Unpublished data.
23. Lawson, P. A., and M. D. Collins. 1996. Description of Bartonella clarridgeiae sp. nov. isolated from the cat of a patient with Bartonella henselae septicemia. Med. Microbiol. Lett. 5:64-73.
24. Lee, W. R., D. D. Jagdish, and R. Reid. 1994. Bacillary angiomatosis of the conjunctiva. Am. J. Ophthal. 118:152-157.
25. Margileth, A. M. 1992. Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr. Infect. Dis. J. 11:474-478.
26. Maurin, M., H. Lepocher, D. Mallet, and D. Raoult. 1993. Antibiotic susceptibilities of Afipia felis in axenic medium and in cells. Antimicrob. Agents Chemother. 37:1410-1413.
27. Maurin, M., and D. Raoult. 1993. Antimicrobial susceptibility of Rochalimaea quintana, Rochalimaea vinsonii, and the newly recognized Rochalimaea henselae. J. Antimicrob. Chemother. 32:587-594.
28. Maurin, M., S. Gasquet, C. Ducco, and D. Raoult. 1995. MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates. Antimicrob Agents Chemother. 39:2387-2391.
29. Mui, B. S. K., M. E. Mulligan, and W. L. George. 1990. Response of HIV-associated disseminated cat scratch disease to treatment with doxycycline. Am. J. Med. 89:229-231.
30. Musso, D., M. Drancourt, and D. Raoult. 1995. Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae. J. Antimicrob Chemother. 36:101-108.
31. Papich, M. G. 1995. Antimicrobial drugs, p. 272-283. In S. J. Ettinger and E. C. Feldman (ed.), Textbook of veterinary internal medicine: diseases of the dog and cat, 4th ed. W. B. Saunders, Philadelphia, Pa.
32. Pocidalo, J.-J. 1989. Use of fluoroquinolones for intracellular pathogens. Rev. Infect. Dis. 11:S979-S984.
33. Regnery, R. L., J. A. Rooney, A. M. Johnson, et al. 1996. Experimentally induced Bartonella henselae infections followed by challenge exposure and antimicrobial therapy in cats. Am. J. Vet. Res. 57:1714-1719.
34. Riond, J.-L., S. L. Vaden, and J. E. Riviere. 1990. Comparative pharmacokinetics of doxycycline in cats and dogs. J. Vet. Pharmacol. Ther. 13:415-424.
35. Scheer, M. 1987. Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Vet. Med. Rev. 2:104-118.
36. Schwartzman, W. A. 1992. Infections due to Rochalimaea: the expanding clinical spectrum. Clin. Infect. Dis. 15:893-902.
37. Steers, E., E. L. Foltz, B. X. Graves, and J. Riden. 1959. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot. Chemother. 9:307-311.
38. Wilson, K. H., R. B. Blitchington, and R. C. Greene. 1990. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J. Clin. Microbiol. 28:1942-1946.